Skip to main content

Advertisement

Table 4 Motor outcomes and complications in patients with central metastasis based on the treatment modalities, namely, MRS vs SRT/SRS

From: Early motor function after local treatment of brain metastases in the motor cortex region with stereotactic radiotherapy/radiosurgery or microsurgical resection: a retrospective study of two consecutive cohorts

  Overall MRS SRT/SRS p
Muscle strength (BMRC)*     
 Arm 4.5 4.1 4.7 n.s.
 Leg 4.6 4.4 4.8 n.s.
Patients with motor improvements (%) 44.8% 54.2% 16.7% <0.042
Motoric Improvement (BMRC)*     
 Arm   0.5 0.1 n.s.
 Leg   0.4 0.0 <0.05
Motoric Deterioration 10.7% 11.1% 5.1% 0.1
Dexamethasone daily dose (mg)   4.5 9.5 <0.001
Overall complications 31.9% 25.9% 35.7% n.s.
 Local 13% 18.5% 9.5% n.s.
 Systemic 18.8% 7.4% 26.2% <0.06
  1. SRT/SRS Stereotactic radiotherapy or radiosurgery, MRS Microsurgery, BMRC British Medical Research Council, n.s not significant
  2. * mean value